Exemptia

Exemptia Indications/Uses

adalimumab

Manufacturer:

Zydus Cadila

Distributor:

Maxxcare

Marketer:

Mega Lifesciences
Full Prescribing Info
Indications/Uses
Exemptia is indicated for following conditions: Rheumatoid Arthritis (RA) (in adults): Moderate to severe, active RA; Severe, active and progressive RA.
Juvenile Idiopathic Arthritis (JIA): Moderate to severe active polyarticular JIA in pediatric patients of 2 years of age and older; Active enthesitis related arthritis in patients of 6 years of age and older.
Psoriatic Arthritis (PsA): Active and progressive PsA in adults.
Ankylosing Spondylitis (AS) and axial spondyloarthritis without radiographic evidence of AS: Active AS and axial spondyloarthritis without radiographic evidence of AS in adults.
Crohn's Disease (CD): Patients (adult patients and pediatric patients of 6 years and older) with moderate to severe active CD who have had inadequate response to conventional therapy or who are intolerant to or have medical contraindications for such therapies.
Ulcerative Colitis (UC): Adult patients with moderate to severe active UC who have had an inadequate response to conventional therapy or who are intolerant to or have medical contraindications for such therapies.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in